aiqbench analysis

RiverCell is raising a $25M seed round to build a "world model" of the human cell, leveraging AI techniques typically used in large language models but applied to biological data. This initiative represents a significant step toward using machine learning for predictive biology and drug discovery, moving beyond simple pattern recognition to simulating complex cellular environments.